HY-139908

MERS-CoV-IN-1

MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1].

957.61 €

HY-135855

SARS-CoV-IN-1

SARS-CoV-IN-1 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-1 shows anti-Coronavirus activity with an EC50 of 4.9 μM in Vero cells. SARS-CoV-IN-1 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 15.4 and 133.2 nM; and IC90s of 25.7 and 459.1 nM; respectively. Antimalarial and antiviral activities[1].

3738.43 €

MBS5767569-10mg

SARS-CoV-IN-1

1706.39 €

T60686-1g

SARS-CoV-2 Mpro-IN-1

SARS-CoV-2 Mpro-IN-1

Ask for quotation

T60686-1mg

SARS-CoV-2 Mpro-IN-1

SARS-CoV-2 Mpro-IN-1

Ask for quotation

T60686-50mg

SARS-CoV-2 Mpro-IN-1

SARS-CoV-2 Mpro-IN-1

Ask for quotation